Alpron

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

38 Suppliers, 23 USDMF, 11 CEP/COS, 1 JDMF, 3 EU WC, 37 KDMF, 14 NDC API, 15 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

3 Suppliers

3 Suppliers

DOSSIERs // Finished Dosage Forms

308 Dossiers, 113 FDA Orange Book, 82 Europe, 29 Canada, 23 Australia, 25 South Africa, 36 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 250MG, TABLET;ORAL - 375MG, TABLET;ORAL - 500MG, SUSPENSION;ORAL - 25MG/ML, TABLET, DELAYED RELEASE;ORAL - 375MG, TABLET, DELAYED RELEASE;ORAL - 500MG, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 33 BASF, 32 Kerry, 27 Roquette, 14 Corel Pharma Chem, 14 Seppic, 13 Ideal Cures Pvt Ltd, 12 Microlex e.U, 12 Sigachi Industries, 12 Gangwal Chemicals, 10 Gangwal Healthcare, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Boai NKY Pharmaceuticals Ltd, 8 Actylis, 6 DFE Pharma, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 Nanjing Well Pharmaceutical, 6 SPI Pharma, 6 Lonza Capsugel, 4 Ingredion Pharma Solutions, 4 Ulanqab Kema New Material, 4 Vasa Pharmachem, 4 Pharmatrans-Sanaq, 4 Prachin Chemical, 3 Kima Chemical, 3 Doshion Polyscience, 3 DKSH, 2 Alcedo Pharmachem, 2 Seqens, 2 Finar, 2 Nomisma Healthcare, 2 Jai Radhe Sales, 2 The Dow Chemical Company, 2 Aeon Procare, 2 Evonik, 1 Pfanstiehl, 1 Vertellus, 1 Nanjing Bold Chemical, 1 Zhejiang Huakang Pharmaceutical, 1 ACG Worldwide, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 1 Clariant, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Rochem International Inc, 1 Shanghai Welltone Material Technology Co., Ltd

EXCIPIENTS BY APPLICATIONS

71 Fillers, Diluents & Binders, 69 Coating Systems & Additives, 42 Disintegrants & Superdisintegrants, 41 Controlled & Modified Release, 36 Direct Compression, 32 Solubilizers, 28 Thickeners and Stabilizers, 26 Granulation, 22 Film Formers & Plasticizers, 20 Taste Masking, 17 Co-Processed Excipients, 17 Lubricants & Glidants, 16 Parenteral, 15 Topical, 11 Chewable & Orodispersible Aids, 6 API Stability Enhancers, 6 Emulsifying Agents, 5 Empty Capsules, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

15 US Medicaid Prescriptions, 69 Finished Drug Prices

MARKET PLACE

28 APIs, 3 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

3 BioAnalytical Methods, 3 EDQM Standards, 5 USP Standards, 8 Other Ref. Standards

DIGITAL CONTENT

3 Data Compilation & Company Tracker #PharmaFlow, 33 News

Annual Sales of Alpron reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Alpron

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

38 Suppliers

23 USDMF

11 CEP/COS

1 JDMF

3 EU WC

37 KDMF

14 NDC API

15 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

3 Suppliers

DOSSIERs // Finished Dosage Forms

308 Dossiers

113 FDA Orange Book

82 Europe

29 Canada

23 Australia

25 South Africa

36 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 250MG

TABLET;ORAL - 375MG

TABLET;ORAL - 500MG

SUSPENSION;ORAL - 25MG/ML

TABLET, DELAYED RELEASE;ORAL - 375MG

TABLET, DELAYED RELEASE;ORAL - 500MG

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

33 BASF

32 Kerry

27 Roquette

14 Corel Pharma Chem

14 Seppic

13 Ideal Cures Pvt Ltd

12 Microlex e.U

12 Sigachi Industries

12 Gangwal Chemicals

10 Gangwal Healthcare

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 Boai NKY Pharmaceuticals Ltd

8 Actylis

6 DFE Pharma

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 Nanjing Well Pharmaceutical

6 SPI Pharma

6 Lonza Capsugel

4 Ingredion Pharma Solutions

4 Ulanqab Kema New Material

4 Vasa Pharmachem

4 Pharmatrans-Sanaq

4 Prachin Chemical

3 Kima Chemical

3 Doshion Polyscience

3 DKSH

2 Alcedo Pharmachem

2 Seqens

2 Finar

2 Nomisma Healthcare

2 Jai Radhe Sales

2 The Dow Chemical Company

2 Aeon Procare

2 Evonik

1 Pfanstiehl

1 Vertellus

1 Nanjing Bold Chemical

1 Zhejiang Huakang Pharmaceutical

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons